Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial

University of the Witwatersrand. Faculty of Health Sciences. Department of Internal Medicine. Johannesburg, South Africa./ Right to Care Johannesburg. South Africa.
Harvard School of Public Health. Center for Biostatistics in AIDS Research. Boston, United States of America.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Durban University of technology. Durban, South Africa.
University of the Witwatersrand. Faculty of Health Sciences. Department of Internal Medicine. Johannesburg, South Africa.
University of Zimbabwe College of Health Sciences. Harare, Zimbabwe.
IMPACTA Peru. San Miguel, Peru
Alpert Medical School of Brown University. Providence, Rhode Island, United States of America.
YRGCARE Medical Centre. Chennai, India
University of Zimbabwe College of Health Sciences. Harare, Zimbabwe.
University of Colorado School of Medicine. Department of Medicine. Division of Infectious Diseases. Aurora, United States of America.

Abstract

Worldwide, 50% of human immunodeficiency virus (HIV)-infected people are women. This study was to evaluate whether the safety and efficacy outcomes of three initial antiretroviral regimens (ARVs) differed by sex.

Keywords

ARVs
Clinical studies
HIV
Resource-limited settings
Women

Citation

FIRNHABER, Cynthia. et al. Differences in Antiretroviral Safety and Efficacy by Sex in a Multi-National Randomized Clinical Trial. HIV clinical trials, v. 16, n. 3, p. 89–99, 2015

DOI

10.1179/1528433614Z.0000000013

ISSN

1528-4336

Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/29552

Type

Copyright

Open access

Sustainable Development Goals

Collections

Share

Statistics

Metadata

Author

Affilliation

Abstract

Keywords

Citation

DOI

ISSN